ArticleJournal of investigative medicine high impact case reports

Tyrosine Kinase Inhibitors' Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer.

Ghada Elshimy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.